Package 51662-1238-1

Brand: naloxone hydrochloride

Generic: naloxone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 51662-1238-1
Digits Only 5166212381
Product NDC 51662-1238
Product ID 51662-1238_ef6a784b-3d10-da51-e053-2a95a90ad05d
Description

1 mL in 1 CARTRIDGE (51662-1238-1)

Marketing

Marketing Status
Marketed Since 2018-09-03
Brand naloxone hydrochloride
Generic naloxone hydrochloride
Sample Package No

Linked Drug Pages (1)

NALOXONE HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "ef6a784b-3d10-da51-e053-2a95a90ad05d", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1191234"], "spl_set_id": ["74fcd243-94b3-ec77-e053-2991aa0a229c"], "manufacturer_name": ["HF Acquisition Co. LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 mL in 1 CARTRIDGE (51662-1238-1)", "package_ndc": "51662-1238-1", "marketing_start_date": "20180903"}], "brand_name": "NALOXONE HYDROCHLORIDE", "product_id": "51662-1238_ef6a784b-3d10-da51-e053-2a95a90ad05d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "51662-1238", "generic_name": "NALOXONE HYDROCHLORIDE", "labeler_name": "HF Acquisition Co. LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NALOXONE HYDROCHLORIDE", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA070172", "marketing_category": "ANDA", "marketing_start_date": "20180903", "listing_expiration_date": "20261231"}